CN106606744A - Combination medicament for treating type 2 diabetes mellitus - Google Patents
Combination medicament for treating type 2 diabetes mellitus Download PDFInfo
- Publication number
- CN106606744A CN106606744A CN201710076490.7A CN201710076490A CN106606744A CN 106606744 A CN106606744 A CN 106606744A CN 201710076490 A CN201710076490 A CN 201710076490A CN 106606744 A CN106606744 A CN 106606744A
- Authority
- CN
- China
- Prior art keywords
- parts
- leaf
- medicine
- diabetes
- fruit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/09—Lichens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/76—Salicaceae (Willow family), e.g. poplar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a combination medicament for treating type 2 diabetes mellitus. The combination medicament is prepared from the 16 medicinal herbs of radix astragali seu hedysari, ginseng, fructus ligustri lucidi, fructus lycii, charred bighead atractylodes rhizome, radix rehmanniae preparata, radix puerariae, radix curcumae, endothelium corneum gigeriae galli, purslane herb, taraxacum mongolicum, radix aucklandiae, lichen, white radish, sweet potato leaf, willow leaf and locust tree leaf. The combination medicament can clear away heat, resolve depression, remove stasis, radically reform, recover the body of a patient as strong as before and radically cure diabetes mellitus, and has the curative effects of quick response, short treatment course, high cure rate and low recurrence rate.
Description
Technical field
The invention belongs to technical field of traditional Chinese medicines, more particularly to a kind of composition of medicine for treating type II diabetes.
Background technology
Diabetes（What the traditional Chinese medical science was called quenches one's thirst）It is the relatively common disease of present society, and with growth in the living standard,
The incidence of disease more and more higher of diabetes.Doctor trained in Western medicine thinks, diabetes be due to internal insulin deficit or insulin in target cell not
The physiological action that can bring into normal play and a kind of syndrome of sugar, albumen and fat metabolic disturbance for causing.The essential characteristic of diabetes
Be long term hyperglycemia, can damage the multiple systems of whole body, major determinant cardiovascular system, prolonged illness can also result in eye, kidney, nerve,
The chronic progressive external pathology of the tissues such as heart, blood vessel, causes functional defect and exhaustion.The symptom of diabetes can be divided into two big class：
One big class is the performance relevant with metabolic disorder, especially " three-many-one-little " relevant with hyperglycaemia, is more common in IDDM；
Type II diabetes is not often fairly obvious or only part shows.Type II diabetes people's blood glucose rise is primarily due to gastrointestinal absorption
Sugar can not in time be sent to the periphery position such as four limbs, skin, the cell at these positions can not fully consume blood sugar, participate in consuming
The cell quantity of blood sugar is reduced, and finally results in the rising of blood sugar.
Traditional theory thinks that the cause of disease of diabetes is relevant with following three kinds of factors：1. inherent cause, diabetes are heredity
Disease, genetics research shows, onset diabetes rate in blood lineage relatives with there were significant differences in non-blood lineage relatives, the former relatively after
Person is higher by 5 times or so.The importance of inherent cause is 50% or so in the cause of disease of IDDM, and in the disease of type II diabetes
The importance of inherent cause is up to more than 90% because in；2. mental element, since nearly period, domestic and abroad scholar confirms that mental element exists
Diabetes occur, developing effect, it is believed that the exciting and various stress situation of the anxiety, mood along with spirit, can cause
Rise a large amount of secretions of hyperglycemic hormone, such as growth hormone, norepinephrine, glucagon and cortex hormone of aadrenaline；3.
Fat factor, it is now recognized that obesity is an important risk factor of diabetes, the maturity-onset diabetes patient of 60%-80% is sending out
Overweight people is before disease, fat degree is proportional with the incidence of disease of diabetes, and with advancing age, physical exertion
When gradually decreasing, human muscle is also changing with the ratio of fat, and from 25 years old to 75 years old, musculature was gradually decreased, by accounting for body
The 47% of weight is reduced to 36%, and fat increases to 36% by 20%, and this is the elderly, sugar in particularly fat blubbery the elderly
The one of the main reasons of the sick showed increased of urine；4. long-term hyperphagia, hyperphagia and uncontrolled, overnutrition make original dive
The insulin β cells of hypofunction over-burden, and induced Diabetic.Define both at home and abroad now " life is more rich,
Body is more plentiful, and diabetes more increase " concept.
At present, two kinds of Chinese traditional treatment and western medical treatment are divided into the treatment of diabetes both at home and abroad, Western medicine mainly by insulin,
Administration time is long, large side effects, and capilary can occur pathology；With biguanides, curative effect is low, large side effects.Cure in China
Treating diabetes has long history, and since nearly period, more tired more Chinese medicinal formulaes are disclosed in generation, but make a general survey of these technologies, absolutely
To solve, diabetes are yin-yang deficiency to be aided with activating blood and removing stasis drug to great majority to control a little, and its therapeutic effect is not ideal enough.Such as
The Chinese medicine of diabetes is treated disclosed in CN101700354B patents, its formula is：American Ginseng 1-5, wind-weed 2-6 parts, gypsum 1-5
Part, balsam pear 3-8 parts, silk cocoon 2-6 parts, Radix Astragali 1-5 parts, Chinese yam 1-5 parts, dried rhizome of rehmannia 1-5 parts, radix scrophulariae 1-5 parts, radix glehniae 1-5 parts, wheat
Winter 1-5 part, radix polygonati officinalis 1-5 parts, sealwort 1-5 parts, root of Chinese trichosanthes 1-5 parts, the membrane of a chicken's gizzard 1-5 parts, coptis 1-5 parts, dogwood fruit 1-5 parts, Chinese holly
Matrimony vine 2-7 parts, fruit of glossy privet 2-7 parts, barrenwort 1-5 parts；The medicine of the disclosed treatment diabetes of CN103751344A, it is by effective
Composition and/or chemically acceptable carrier are constituted, and its active ingredient is by monkshood 5-15 parts, Chinese cassia tree 1-5 parts, Morinda officinalis 5-15 parts
Make, etc..
The content of the invention
Defect of the present invention for prior art, there is provided a kind of composition of medicine for treating type II diabetes, Neng Gouyou
Effect ground treatment type II diabetes, cure rate is high, and recurrence rate is low.
Realize that above-mentioned purpose is adopted the technical scheme that：A kind of composition of medicine for treating type II diabetes, by under
The medicine of row weight portion is made：Radix Astragali 15-20 parts, ginseng 15-20 parts, fruit of glossy privet 10-15 parts, fruit of Chinese wolfberry 15-25 parts, Rhizoma Atractylodis Macrocephalae preparata
10-15 parts, cultivated land 15-20 parts, root of kudzu vine 15-20 parts, root tuber of aromatic turmeric 8-10 parts, the membrane of a chicken's gizzard 10-15 parts, purslane 8-10 parts, dandelion
8-10 parts, banksia rose 5-8 parts, lichens 20-30 parts, ternip tassel 20-30 parts, sweet potato leaves 20-30 part, willow leaf 15-20 parts, acacia leaf
15-20 parts.
The composition of medicine for treating type II diabetes, is made up of the medicine of following weight portion：
15 parts of the Radix Astragali, 15 parts of ginseng, 10 parts of the fruit of glossy privet, 20 parts of the fruit of Chinese wolfberry, 10 parts of Rhizoma Atractylodis Macrocephalae preparata, 15 parts of cultivated land, 15 parts of the root of kudzu vine, root tuber of aromatic turmeric
10 parts, 15 parts of the membrane of a chicken's gizzard, 10 parts of purslane, 10 parts of dandelion, 5 parts of the banksia rose, 30 parts of lichens, 30 parts of ternip tassel, sweet potato leaves 30
Part, 20 parts of willow leaf, 20 parts of acacia leaf.The scheme of the present embodiment is applied to initial stage patients with NIDDM.
The composition of medicine for treating type II diabetes, is made up of the medicine of following weight portion：
20 parts of the Radix Astragali, 20 parts of ginseng, 15 parts of the fruit of glossy privet, 25 parts of the fruit of Chinese wolfberry, 10 parts of Rhizoma Atractylodis Macrocephalae preparata, 20 parts of cultivated land, 20 parts of the root of kudzu vine, root tuber of aromatic turmeric
8 parts, 10 parts of the membrane of a chicken's gizzard, 8 parts of purslane, 8 parts of dandelion, 8 parts of the banksia rose, 20 parts of lichens, 20 parts of ternip tassel, 20 parts of sweet potato leaves, willow
15 parts of leaf, 15 parts of acacia leaf.The scheme of the present embodiment is applied to middle and later periods patients with NIDDM.
The ternip tassel and sweet potato leaves were plucked before the Mid-autumn Festival, and willow leaf and acacia leaf were plucked before clear and bright solar term.
The ternip tassel, sweet potato leaves, willow leaf and acacia leaf adopt low temperature drying, drying temperature to be less than 50 DEG C.
The ternip tassel, sweet potato leaves, willow leaf and acacia leaf are dried using normal-temperature vacuum.
Inventor combines traditional cognitive, and by thinking to modern society's life mode and investigating for structure, with
The affluence of life, diet loses restraining, and how quiet few dynamic overnutrition live, digestion and absorption function reduction, for a long time in spirit
Tense situation, causes liver kidney can't bear the heavy load, and the weather such as each portion's internal organs and hematological system stasis of blood product detoxification is induced Diabetic master
Want factor.In the course of time stasis of blood product benefit is more, and human body weakness day, very bad old practices die hard, and fat, edema is led to assertive evidence, so closely period with
Carry out onset diabetes rate more and more higher, period of disease constantly shifts to an earlier date.Modern Western medicine treatment long-term prescription only asks control, and its side effect
Easily cause its disease, among gingerly, mental burden is more and more weighed minimal invasive treatment.The traditional Chinese medical science is more to be controlled with asthenic symptoms opinion, imposes the moon
It is positive and to mend be First Essential, or be aided with cool blood enrich blood, medicine promoting blood circulation and removing blood stasis, but do not know that stasis of blood product is not removed, constipation is obstructed, it is difficult to
Speech is mended, and only the new stasis of blood can be brought to accumulate.So the present invention is started with by stasis of blood product and blood endotoxin in human body and internal organs is excluded, simultaneous to impose
Clearing heat and detoxicating, cool blood enriches blood, promoting blood circulation and removing blood stasis, soothing liver-qi stagnation, radicallys reform, then row nourishment for vitality again, strong end is consolidated, with up to standard
Sheet and the effect controlled, assign patient to strengthen physique.
The main advantages of the present invention being：
Composition of medicine for the treating type II diabetes broken stasis of blood detoxification first of the present invention, heat-clearing solution is strongly fragrant, and except stasis eliminatings product, original is clear
Source, thus paddy essence be able to intake, blood be able to direct motion, sugared poison is excluded, and insulin cell is regenerated, then enriching yin mend
Sun, makes patient's human body strong as before, and diabetes can be effected a radical cure, so instant effect, short treating period cure rate height, recurrence rate can be received
Low curative effect.Meanwhile, the medicine lid has no toxic side effect, and has peculiar to carrying obesity, hypertension, high fat of blood, fatty liver
Curative effect, can also receive fat-reducing, beauty, prevent the good result of diabetes.
Specific embodiment
The composition of medicine for treating type II diabetes of the present invention, is made up of the medicine of following weight portion：Radix Astragali 15-20
Part, ginseng 15-20 parts, fruit of glossy privet 10-15 parts, fruit of Chinese wolfberry 15-25 parts, Rhizoma Atractylodis Macrocephalae preparata 10-15 parts, cultivated land 15-20 parts, root of kudzu vine 15-
20 parts, root tuber of aromatic turmeric 8-10 parts, the membrane of a chicken's gizzard 10-15 parts, purslane 8-10 parts, dandelion 8-10 parts, banksia rose 5-8 parts, lichens 20-30
Part, ternip tassel 20-30 parts, sweet potato leaves 20-30 part, willow leaf 15-20 parts, acacia leaf 15-20 parts.Wherein：Ternip tassel and Ipomoea batatas
Leaf can be plucked before the Mid-autumn Festival, and willow leaf and acacia leaf can be plucked before clear and bright solar term, and this few taste tender leaf raw material is cleaned after winning
Dry in the shade or low temperature drying, drying temperature is less than 50 DEG C, or normal-temperature vacuum is dried.All medicinal materials are crushed respectively after getting all the ready, cross 200
~ 300 mesh sieves make the direct use of smalls or make the water-bindered pill according to a conventional method and take.When taking, 9 ~ 15 grams every time, 3 times a day, meal
After take, 30 days be a course for the treatment of.
Embodiment one
The composition of medicine for treating type II diabetes of the present invention, the weight of its each component can be：15 parts of the Radix Astragali,
15 parts of ginseng, 10 parts of the fruit of glossy privet, 15 parts of the fruit of Chinese wolfberry, 10 parts of Rhizoma Atractylodis Macrocephalae preparata, 15 parts of cultivated land, 15 parts of the root of kudzu vine, 8 parts of root tuber of aromatic turmeric, the membrane of a chicken's gizzard 10
Part, 8 parts of purslane, 8 parts of dandelion, 5 parts of the banksia rose, 20 parts of lichens, 20 parts of ternip tassel, 20 parts of sweet potato leaves, 15 parts of willow leaf, acacia
15 parts of leaf.
Embodiment two
The composition of medicine for treating type II diabetes of the present invention, the weight portion of its each component is with also can also be：The Radix Astragali 18
Part, 18 parts of ginseng, 13 parts of the fruit of glossy privet, 20 parts of the fruit of Chinese wolfberry, 13 parts of Rhizoma Atractylodis Macrocephalae preparata, 18 parts of cultivated land, 18 parts of the root of kudzu vine, 9 parts of root tuber of aromatic turmeric, the membrane of a chicken's gizzard
13 parts, 9 parts of purslane, 6 parts of dandelion, 6 parts of the banksia rose, 25 parts of lichens, 25 parts of ternip tassel, 25 parts of sweet potato leaves, 17 parts of willow leaf, ocean
17 parts of Chinese scholartree leaf.
Embodiment three
The composition of medicine for treating type II diabetes of the present invention, the weight of its each component can also be：The Radix Astragali 20
Part, 20 parts of ginseng, 15 parts of the fruit of glossy privet, 25 parts of the fruit of Chinese wolfberry, 15 parts of Rhizoma Atractylodis Macrocephalae preparata, 20 parts of cultivated land, 20 parts of the root of kudzu vine, 10 parts of root tuber of aromatic turmeric, in chicken
15 parts of gold, 10 parts of purslane, 10 parts of dandelion, 8 parts of the banksia rose, 30 parts of lichens, 30 parts of ternip tassel, 30 parts of sweet potato leaves, willow leaf 20
Part, 20 parts of acacia leaf.
Example IV
15 parts of the Radix Astragali, 15 parts of ginseng, 10 parts of the fruit of glossy privet, 20 parts of the fruit of Chinese wolfberry, 10 parts of Rhizoma Atractylodis Macrocephalae preparata, 15 parts of cultivated land, 15 parts of the root of kudzu vine, root tuber of aromatic turmeric
10 parts, 15 parts of the membrane of a chicken's gizzard, 10 parts of purslane, 10 parts of dandelion, 5 parts of the banksia rose, 30 parts of lichens, 30 parts of ternip tassel, sweet potato leaves 30
Part, 20 parts of willow leaf, 20 parts of acacia leaf.The scheme of the present embodiment be applied to initial stage patients with NIDDM and obesity, high fat of blood,
Patients with Fatty Liver.
Embodiment five
20 parts of the Radix Astragali, 20 parts of ginseng, 15 parts of the fruit of glossy privet, 25 parts of the fruit of Chinese wolfberry, 10 parts of Rhizoma Atractylodis Macrocephalae preparata, 20 parts of cultivated land, 20 parts of the root of kudzu vine, root tuber of aromatic turmeric
8 parts, 10 parts of the membrane of a chicken's gizzard, 8 parts of purslane, 8 parts of dandelion, 8 parts of the banksia rose, 20 parts of lichens, 20 parts of ternip tassel, 20 parts of sweet potato leaves, willow
15 parts of leaf, 15 parts of acacia leaf.The scheme of the present embodiment is applied to intermediary and later stages patients with NIDDM.
The drug regimen of the present invention cured the clinical testing of special first affiliated hospital since 2012 in Nanyang, successively to 128
Example diabetic treated, wherein the male sex 79, accounts for 61.7%；Women 49, accounts for 48.3%；Minimum 45 years old of age, most
Big 79 years old, average age 58 years old；Wherein 45-55 year 43,55-65 year 52, over-65s 33；Wherein the course of disease is most short
6 months, 10 years most long 03 monthly average courses of disease 5 months 6 years.The drug therapy of the Jing present invention, diabetes, hypertension, high blood
The symptoms such as fat are wholly absent, and stable without recidivist 112, and cure rate is 87.5%；Symptom part improver 8, total effective rate
93.8%；Cure to be discontinued in patient and there are within 1 year 8 repeatedly later, recurrence rate is 7.1%.
Model case
Case 1
Chen, man, 36 years old, Nanyang Tanghe County owner of a private enterprise, the first visit of March 6 in 2012, readme diabetes half a year, duration head
Dizzy, headache, weakness of limbs, no spirit, hospital diagnosis fasting blood-glucose 11.0, without glucose in urine, glycosylated hemoglobin 6.3, empty stomach pancreas
Island element 5.4, human body is more fat.Method of administration, each 10g, three times a day, the morning, noon and afternoon respectively take once after meal, three courses for the treatment of of taking medicine
Afterwards, Jing examination in hospital, indices recover normal, and subjective symptoms disappears；Continue to take medicine six months and maintain, it is daily sooner or later each after meal
Once, lose weight 9kg, physically and mentally healthy, pays a return visit 3 years, and indices are again without bounce-back after drug withdrawal.
Case 2
Zhang, female, 62 years old, Nanyang Neixiang County retired cadre, patient's readme memory suffered from diabetes about 7 years, conscious weak,
Urinate many frequent micturitions, Low Back Pain is simultaneously easily sprained, and layer is to examination in hospital glucose in urine ++, fasting blood-glucose 8.7, do not take remedy measures, self control
Diet processed is maintained.To in July, 2012, there is suddenly eye-blurred in patient, and trick pain, palpitation and short breath, from head to foot itch, oral cavity are burst
The symptoms such as ulcer, weak, fash of having a sleepless night.Jing City Hospitals inspections are diagnosed as type II diabetes, hospitalization, beat insulin promise and
Spirit 2 times a day, half an hour beats 26 units of novolin before lunch, under a.p beat 22 units of promise and woods, during treatment simultaneously
Send out disease not anti-reflection to increase（Urine proteins ++++, glucose in urine ++++, cardiac extra systole, cardiac arrhythmia, multiple hepatorenal cyst, 1/3 loss of tooth
Eyeground is muddy.People is yellow black and thin, and body weight falls sharply 20kg in one month, and weak few speech, insomnia is impatient, loses healing confidence.2013
On March 5, in is to hospital, and clinical disease dignity color is steel gray, burned black to become thin, and lazy speech of speaking in a low voice, lingual diagnosis tongue body is livid purple and aged, and turbid tongue is thick
It is greasy, mouth raw meat halitosis.Doctor's advice take the present invention composition of medicine, each 15g, 3 times a day, morning, noon and afternoon one after each meal, stop injection
Insulin.After medication 40 days, patient's drinking-water enuresis nocturna is reduced, and hypoglycemia disappears, and remaining disease disappears.After continuing to take medicine four months, face
Bed symptom disappears, and the state of mind has greatly improvement, checks physical and chemical index glycosylated hemoglobin 6.8, and Urine proteins, fatty liver disappear, urine
Sugar+, increased weight 3kg, patient is placed in confidence and increases.Doctor's advice continues to take medicine and maintains, and each 10g is daily sooner or later each 1 time, takes 4
After the individual course for the treatment of, Jing checks, patient's items physical and chemical index is normal, and eyesight, heart etc. recover normal, and Jing ultrasound diagnosis, hepatorenal cyst disappears
Lose, physical recovery health.Pay a return visit 3 years, then without repeatedly.
Case 3
What certain, man, 72 years old, Nanyang Nanzhao County peasant, August comes to go to a doctor on the 2nd within 2014, readme diabetes 10 years, feels disease
Shape is weak, thirsty, urinates many frequent micturitions, and with hypertension, hyperlipemia, and human body is had a haggard face black and thin, neurolysis, pressure
It is heavy, the hypoglycemic medicine such as long-term taking oral insulin, melbine, poor effect.The composition of medicine of the present invention is taken, every time
15g, 3 times a day, and the morning, noon and afternoon service once after meal.After serveing on three courses for the treatment of, thirsty, many frequent micturition symptom mitigations of urine, blood pressure
Recover normal；Continue three courses for the treatment of of taking medicine, Jing examination in hospital, indices recover normal, and subjective symptoms all disappears；Take medicine again
Maintain within six months, each 10g, 2 times a day, sooner or later each after meal once to pay a return visit 3 years, complexion is smooth, physically and mentally healthy, each after drug withdrawal
Item index is again without bounce-back.
Case 4
Lee, man, 49 years old, Nanyang Wolong District self-employed businessman, on July 9th, 2012, the hospital that comes sought medical advice, and readme body obesity is
Have 7 years, uncomfortable in chest, weak, sitting and lying is all gaspd, chest pain often has a strong impact on work.Clinical examination, height
1.68m, body weight 106.5kg, and have the diseases such as hypertension, high fat of blood, fatty liver, edema.Doctor's advice takes the composition of medicine of the present invention,
Each 15g, 3 times a day, morning, noon and afternoon one after each meal, and greasy, drinks of stopping eating, after taking medicine 30 days, weight loss 4.2kg, pant,
The subjective symptoms such as chest pain disappear；Continue two courses for the treatment of of taking medicine, on inspection body weight subtracts again 15kg, weak, hypertension, high blood
The symptoms such as fat, fatty liver, edema disappear, and activity is freely.Doctor's advice continues to take medicine, each 10g, and the daily morning and evening is each after meal once, limit
Edible oil is greasy, avoids water of drinking；Six courses for the treatment of are taken again, and on inspection, body weight reduces to 72kg, and figure is normal, and spirit is multiple just, and work is strong,
Hale and hearty, happiness is very；Pay a return visit after 1 year, body weight reduces to again 67kg, and again without bounce-back.
Finally illustrate, above example is only to illustrate technical scheme and unrestricted, and this area is common
Other modifications or equivalent that technical staff is made to technical scheme, without departing from technical solution of the present invention
Spirit and scope, all should cover in the middle of scope of the presently claimed invention.
Claims (6)
1. a kind of composition of medicine for treating type II diabetes, it is characterised in that：It is made up of the medicine of following weight portion：It is yellow
Stilbene 15-20 parts, ginseng 15-20 parts, fruit of glossy privet 10-15 parts, fruit of Chinese wolfberry 15-25 parts, Rhizoma Atractylodis Macrocephalae preparata 10-15 parts, cultivated land 15-20 parts,
Root of kudzu vine 15-20 parts, root tuber of aromatic turmeric 8-10 parts, the membrane of a chicken's gizzard 10-15 parts, purslane 8-10 parts, dandelion 8-10 parts, banksia rose 5-8 parts, lichens
20-30 parts, ternip tassel 20-30 parts, sweet potato leaves 20-30 part, willow leaf 15-20 parts, acacia leaf 15-20 parts.
2. it is used to as claimed in claim 1 treat the composition of medicine of type II diabetes, it is characterised in that：It is by following weight portion
Medicine make：
15 parts of the Radix Astragali, 15 parts of ginseng, 10 parts of the fruit of glossy privet, 20 parts of the fruit of Chinese wolfberry, 10 parts of Rhizoma Atractylodis Macrocephalae preparata, 15 parts of cultivated land, 15 parts of the root of kudzu vine, root tuber of aromatic turmeric
10 parts, 15 parts of the membrane of a chicken's gizzard, 10 parts of purslane, 10 parts of dandelion, 5 parts of the banksia rose, 30 parts of lichens, 30 parts of ternip tassel, sweet potato leaves 30
Part, 20 parts of willow leaf, 20 parts of acacia leaf.
3. it is used to as claimed in claim 1 treat the composition of medicine of type II diabetes, it is characterised in that：It is by following weight portion
Medicine make：
20 parts of the Radix Astragali, 20 parts of ginseng, 15 parts of the fruit of glossy privet, 25 parts of the fruit of Chinese wolfberry, 10 parts of Rhizoma Atractylodis Macrocephalae preparata, 20 parts of cultivated land, 20 parts of the root of kudzu vine, root tuber of aromatic turmeric
8 parts, 10 parts of the membrane of a chicken's gizzard, 8 parts of purslane, 8 parts of dandelion, 8 parts of the banksia rose, 20 parts of lichens, 20 parts of ternip tassel, 20 parts of sweet potato leaves, willow
15 parts of leaf, 15 parts of acacia leaf.
4. the composition of medicine for treating type II diabetes as described in claim 1-3 is arbitrary, it is characterised in that：The white trailing plants
Bu Ying and sweet potato leaves were plucked before the Mid-autumn Festival, and willow leaf and acacia leaf were plucked before clear and bright solar term.
5. the composition of medicine for treating type II diabetes as described in claim 1-3 is arbitrary, it is characterised in that：The white trailing plants
Bu Ying, sweet potato leaves, willow leaf and acacia leaf adopt low temperature drying, drying temperature to be less than 50 DEG C.
6. the composition of medicine for treating type II diabetes as described in claim 1-3 is arbitrary, it is characterised in that：The white trailing plants
Bu Ying, sweet potato leaves, willow leaf and acacia leaf are dried using normal-temperature vacuum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710076490.7A CN106606744A (en) | 2017-02-13 | 2017-02-13 | Combination medicament for treating type 2 diabetes mellitus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710076490.7A CN106606744A (en) | 2017-02-13 | 2017-02-13 | Combination medicament for treating type 2 diabetes mellitus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106606744A true CN106606744A (en) | 2017-05-03 |
Family
ID=58636517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710076490.7A Pending CN106606744A (en) | 2017-02-13 | 2017-02-13 | Combination medicament for treating type 2 diabetes mellitus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106606744A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108815264A (en) * | 2018-07-16 | 2018-11-16 | 山东景仲生物科技有限公司 | A kind of reparation liquid of conditioning subhealthy state and chronic disease |
-
2017
- 2017-02-13 CN CN201710076490.7A patent/CN106606744A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108815264A (en) * | 2018-07-16 | 2018-11-16 | 山东景仲生物科技有限公司 | A kind of reparation liquid of conditioning subhealthy state and chronic disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102028900B (en) | Traditional Chinese medicine for treating metabolic syndrome and preparation method thereof | |
| CN103627604B (en) | Health-care wine with function of tonifying kidney and preparation method thereof | |
| CN105250723B (en) | A kind of drug for treating diabetes | |
| CN102552625B (en) | Anti-aging nootropic traditional Chinese medicine and preparation method thereof | |
| CN104286874A (en) | Health porridge for reducing blood glucose | |
| CN1772196A (en) | Heart failure regulating Chinese medicine | |
| CN100493572C (en) | Composition of medication for treating diabetes | |
| CN100579394C (en) | Rice conjee for treating diabetes | |
| CN104645249B (en) | One kind treats treating coronary heart disease and angina pectoris | |
| CN103007159B (en) | Chinese medicinal preparation for correcting pancreas islet function | |
| CN109528968A (en) | A kind of Chinese medicine composition and its preparation method and application for treating diabetes B | |
| CN106606744A (en) | Combination medicament for treating type 2 diabetes mellitus | |
| CN105194301A (en) | Traditional Chinese medicine preparation for treating chronic cardiac failure | |
| CN101843843A (en) | Chinese medicament for treating diabetes | |
| CN112402554B (en) | Traditional Chinese medicine composition for treating leukoencephalopathy and application thereof | |
| CN103393938B (en) | Traditional Chinese medicine composition for reducing blood sugar | |
| CN102580030A (en) | External traditional Chinese medicine composition having effect of reducing blood sugar, preparation prepared from the external traditional Chinese medicine composition, and their preparation method | |
| CN105232754A (en) | Medicine for treating type-II diabetes | |
| CN102552677B (en) | Coptis chinensis and radix rehmanniae Anxiao capsule and preparation method thereof | |
| CN104474103A (en) | Natural plant hypoglycemic agent and preparation method thereof | |
| CN110339323A (en) | A kind of Chinese medicine composition and its preparation method and application for treating bradycardia | |
| CN109395045A (en) | A kind of clearing away heat and eliminating dampeness tune sugar-pill and preparation method thereof for treating diabetes B MIDDLE ENERGIZER DAMPNESS-HEAT | |
| CN114191514B (en) | Traditional Chinese medicine composition for preventing and treating phlegm-damp type obesity | |
| CN114848775B (en) | Traditional Chinese medicine composition for treating acute myocardial infarction as well as traditional Chinese medicine preparation and application thereof | |
| CN100400090C (en) | Medicine composition for treating myasthenia gravis and prepn. method therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170503 |
|
| RJ01 | Rejection of invention patent application after publication |